Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma

BACKGROUND: Although numerous chemotherapeutic agents have been tested, the role of systemic chemotherapy for hepatocellular carcinoma (HCC) has not been clarified. New therapeutic strategies are thus needed to improve outcomes, and we designed this study with new effective drug combination. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Se Hoon, Lee, Yuna, Han, Sang Hoon, Kwon, So Young, Kwon, Oh Sang, Kim, Sun Suk, Kim, Ju Hyun, Park, Yeon Ho, Lee, Jeong Nam, Bang, Soo-Mee, Cho, Eun Kyung, Shin, Dong Bok, Lee, Jae Hoon
Formato: Texto
Lenguaje:English
Publicado: BioMed Central, 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1352374/
https://www.ncbi.nlm.nih.gov/pubmed/16396674
http://dx.doi.org/10.1186/1471-2407-6-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1352374/
https://www.ncbi.nlm.nih.gov/pubmed/16396674
http://dx.doi.org/10.1186/1471-2407-6-3

Ejemplares similares